The objective of the Preclinical Development Program (PDEV) is to accelerate completion of preclinical development, FDA IND clearance, and clinical trial startup for stem cell-based and genetic ...

The mission of California Institute for Regenerative Medicine (CIRM) is to accelerate stem cell treatments to patients with unmet medical needs. With our Clinical Stage Programs, we intend to speed up ...

This meeting of the Application Review Subcommittee will be conducted in person and via noticed teleconference locations, which will be made accessible to the public. Members of the public may attend ...

Meetings of the Grants Review Working Group will be held in a public session format except for the review of individual grant applications which will be conducted in closed session. THE ORDER OF ...

El Instituto de Medicina Regenerativa de California y su Comité de Supervisión de Ciudadanos Independientes, y sus subcomités, cumplen con la Ley de Estadounidenses con Discapacidades (ADA, por sus ...

Candidato terapéutico o dispositivo Plurocart consiste en condrocitos derivados de células madre pluripotentes, sembrados en un armazón; está destinado a tratar el cartílago dañado en la articulación ...

Las neuronas motoras se degeneran y mueren como consecuencia de muchas afecciones, incluidos traumatismos en la médula espinal y sus raíces nerviosas y enfermedades degenerativas como la esclerosis ...

The CIRM iPSC Repository is a collection of induced pluripotent stem cell (iPSC) lines produced from tissue samples obtained from thousands of individuals by researchers in California through funding ...

Welcome to the frequently asked questions (FAQs) page of the California Institute for Regenerative Medicine (CIRM). Here, you’ll find answers to the most common questions you may have on CIRM. CIRM, ...

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

Through its strategic funding of clinical trials, CIRM helps advance innovative stem cell and gene therapy discoveries toward future treatments for patients. CIRM funds clinical trials across a broad ...